Eylea 40mg/ml Injection: Comprehensive Medicine Guide
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026
When to Call Your Doctor IMMEDIATELY
- Sudden vision loss or severe eye pain
- Increasing redness, swelling, or discharge from the eye
- Flashes of light, floaters, or a curtain-like shadow in vision
- Chest pain, shortness of breath, or difficulty speaking
- Signs of allergic reaction: rash, itching, swelling of face or throat
- Severe headache with nausea or vomiting
If experiencing severe symptoms, call emergency services immediately.
What is eylea 40mg/ml injection used for?
This medicine is an intravitreal injection containing aflibercept, used to treat wet age-related macular degeneration, diabetic macular edema, and macular edema from retinal vein occlusion. It works by blocking VEGF to reduce abnormal blood vessel growth and leakage in the eye.
- Generic Name: Aflibercept (40mg/ml)
- Manufacturer: Bayer Zydus Pharma Pvt Ltd
- Form: Allopathy
- Pregnancy Category: Consult doctor
- Prescription Required: Yes
🇮🇳 eylea 40mg/ml injection के बारे में (Hindi Summary)
उपयोग: यह दवा आंखों में इंजेक्शन के रूप में दी जाती है और यह एफ्लिबरसेप्ट नामक सक्रिय तत्व से बनी है। यह उम्र से संबंधित मैक्युलर डिजनरेशन (वेट एएमडी), डायबिटिक मैक्युलर एडिमा, और रेटिनल वेन ऑक्लूजन के कारण होने वाली मैक्युलर एडिमा के इलाज में उपयोग की जाती है। यह आंख में असामान्य रक्त वाहिकाओं की वृद्धि और रिसाव को रोककर दृष्टि को बनाए रखने या सुधारने में मदद करती है। यह केवल योग्य नेत्र रोग विशेषज्ञ द्वारा ही दी जानी चाहिए।
साइड इफेक्ट्स: आम दुष्प्रभावों में आंख में दर्द, लालिमा, आंखों में पानी आना, धुंधली दृष्टि और आंख में कुछ महसूस होना शामिल है। गंभीर दुष्प्रभावों में आंख का संक्रमण (एंडोफ्थेल्माइटिस), रेटिना डिटैचमेंट, और आंखों में दबाव बढ़ना शामिल है। यदि आपको तेज दर्द, दृष्टि में अचानक कमी, या रोशनी में परेशानी हो तो तुरंत डॉक्टर से संपर्क करें।
सुरक्षा सलाह: यह दवा केवल नेत्र रोग विशेषज्ञ द्वारा ही आंख में इंजेक्ट की जानी चाहिए। इंजेक्शन के बाद कुछ समय के लिए दृष्टि धुंधली हो सकती है, इसलिए वाहन न चलाएं। संक्रमण से बचने के लिए डॉक्टर द्वारा बताई गई एंटीबायोटिक आई ड्रॉप्स का उपयोग करें। किसी भी असामान्य लक्षण को तुरंत डॉक्टर को बताएं।
💊 eylea 40mg/ml injection Uses & Benefits
[{"condition":"Neovascular (wet) age-related macular degeneration (AMD)","description":"This medicine is used to treat wet AMD by inhibiting abnormal blood vessel growth and leakage in the macula, thereby preserving and sometimes improving vision.","evidence":"Well-established"},{"condition":"Diabetic macular edema (DME)","description":"It reduces macular inflammation" class="semantic-link" title="Medicines for swelling">swelling and improves vision in patients with diabetic macular edema.","evidence":"Well-established"},{"condition":"Macular edema following retinal vein occlusion (RVO)","description":"This medicine helps resolve macular edema secondary to branch or central retinal vein occlusion, leading to improved visual acuity.","evidence":"Well-established"},{"condition":"Myopic choroidal neovascularization (mCNV)","description":"It is used to treat choroidal neovascularization associated with pathological myopia, preventing further vision loss.","evidence":"Well-established"}]
Off-label uses: [{"condition":"Proliferative diabetic retinopathy","description":"Sometimes used off-label as an adjunct to panretinal photocoagulation or as primary therapy in select cases.","evidence":"Limited"},{"condition":"Retinopathy of prematurity (ROP)","description":"Used off-label in some centers for severe ROP, but not approved for this indication.","evidence":"Limited"}]
Primary treatment for: Neovascular (wet) age-related macular degeneration
Also treats: Diabetic macular edema, Macular edema following retinal vein occlusion, Myopic choroidal neovascularization
📋 Drug Information
| Generic Name(s) | Aflibercept (40mg/ml) |
| Brand Name | eylea 40mg/ml injection |
| Manufacturer | Bayer Zydus Pharma Pvt Ltd |
| Packaging / Form | Varies by brand (Allopathy) |
| Therapeutic Class | OPHTHAL |
| Action Class | Vascular endothelial growth factor (VEGF) inhibitor for AMD |
| Route of Administration | Intravitreal injection (into the eye) |
| Storage | Store refrigerated at 2°C to 8°C. Do not freeze. Keep the vial in the original carton to protect from light. Once opened, use immediately. |
| Shelf Life | Refer to the product packaging for the expiration date. Do not use after the expiry date. |
| WHO Guideline | Not established from the available information. |
| ICMR Guideline | Not established from the available information. |
👨⚕️ Doctor's Practical Tips
Evidence-based practical advice from experienced clinicians
🔍 Is This Medicine Right for Your Symptom?
Educational reference. Always consult a doctor for diagnosis.
🔬 How This Medicine Works (Pharmacology)
Pharmacokinetics
How It Works
Aflibercept is a recombinant fusion protein that acts as a soluble decoy receptor for vascular endothelial growth factor (VEGF). It binds to VEGF-A, VEGF-B, and placental growth factor (PlGF) with high affinity, preventing these ligands from activating their natural receptors (VEGFR-1 and VEGFR-2) on endothelial cells. This inhibition reduces endothelial cell proliferation, neovascularization, and vascular permeability, which are key processes in the pathogenesis of retinal neovascular and edematous diseases.
Mechanism Steps
💡 How to Take eylea 40mg/ml injection
Strength: 40 mg/mL solution for injection (single-use vial).
Dosage Information
| Adult Dosage | The recommended dose is 2 mg (0.05 mL of 40 mg/mL solution) administered by intravitreal injection once monthly for the first three doses, followed by one injection every two months for wet AMD. For diabetic macular edema and retinal vein occlusion, the dose is 2 mg once monthly. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function. |
| Pediatric Dosage | Pediatric dosing is not established from available information. Consult a pediatrician. |
| Elderly Dosage | No specific dose adjustment is required for elderly patients based on age alone. However, individual clinical assessment is advised. |
| Renal Impairment | No dose adjustment is required for renal impairment based on available data. |
| Hepatic Impairment | No dose adjustment is required for hepatic impairment based on available data. |
| Maximum Daily Dose | Not applicable, as this medicine is administered as a single intravitreal injection per treatment session, typically not more than once monthly. |
Dosage Timeline
⏰ What to Do If You Miss a Dose
⚠️ Side Effects of eylea 40mg/ml injection
✅ Common Side Effects
🚨 Serious Side Effects
⚠️ Rare Side Effects
Consult your doctor if you experience any unusual symptoms.
🛡️ Safety & Warnings
🚫 Contraindications
["Active ocular or periocular infection","Active intraocular inflammation","Known hypersensitivity to aflibercept or any excipient"]
⚠️ Warnings & Precautions
["Intravitreal injections may cause endophthalmitis, retinal detachment, and increased intraocular pressure. Proper aseptic technique is essential.","Patients should be monitored for signs of infection or detachment after injection.","Temporary visual disturbances may occur; patients should not drive or operate machinery until vision is clear.","There is a potential risk of arterial thromboembolic events; caution in patients with history of stroke or myocardial infarction.","Use with caution in patients with glaucoma or history of increased intraocular pressure."]
🤱 Lactation Safety
It is not known whether aflibercept is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this medicine is administered to a nursing woman. Consult your doctor to decide whether to continue breastfeeding.
💊 Overdose Management
Overdose with this medicine is unlikely due to its administration by a healthcare professional. If accidental overdose occurs, monitor intraocular pressure and treat symptomatically. Systemic overdose is not expected due to low systemic absorption.
⏰ Missed Dose
This medicine is administered by a healthcare professional. If you miss an appointment for your scheduled injection, contact your ophthalmologist as soon as possible to reschedule. Do not attempt to self-administer.
Additional Safety Advice
This medicine must only be administered by a qualified ophthalmologist using proper aseptic technique. Do not attempt to self-administer. Inform your doctor if you have a history of eye infections, glaucoma, or any heart conditions. After the injection, you may experience temporary visual disturbances; avoid driving or operating machinery until vision clears. Use prescribed antibiotic eye drops as directed to prevent infection. Attend all follow-up appointments for monitoring. Report any signs of infection, such as increasing eye pain, redness, or discharge, without delay.
👴 Special Considerations for Elderly
💡 For Patients Above 65
Elderly patients may have a higher risk of systemic effects and should be monitored closely. No dose adjustment is required based on age alone.
🤰 Pregnancy Planning (TTC)
If you are planning pregnancy, consult your doctor. This medicine should be used during pregnancy only if clearly needed. Effective contraception is recommended during treatment.
🏥 Post-Surgery Considerations
If you have recent eye surgery, inform your ophthalmologist before receiving this injection. The risk of complications may be higher.
🦷 Dental Procedures
No specific precautions for dental procedures. However, inform your dentist about this medicine and any eye conditions.
💚 Lifestyle Tips for Better Results
🏋️ Exercise Considerations
Avoid strenuous exercise or heavy lifting for a few days after the injection to reduce the risk of increased eye pressure or bleeding. Consult your doctor before resuming intense activities.
🥗 Diet Recommendations
💼 Impact on Daily Work & Life
You may need to take time off work for injection appointments and recovery. Temporary vision blurring may affect driving and operating machinery. Plan your schedule accordingly.
🛑 When to Stop This Medicine
Do not stop treatment without consulting your ophthalmologist. Stopping may lead to worsening of the condition and vision loss. Your doctor will decide when to discontinue based on your response and disease status.
📅 Long-Term Use Effects
Long-term use of this medicine may require ongoing monitoring for intraocular pressure, retinal health, and rare systemic events. Repeated injections can maintain vision but may increase the risk of cumulative side effects. Regular follow-up with your ophthalmologist is essential.
🌿 Non-Medicine Approaches
These can complement medicine but do not replace prescribed treatment.
Can be used for certain retinal conditions but may not be as effective for macular edema.
Evidence: Well-establishedRanibizumab or bevacizumab may be alternatives, but require different dosing.
Evidence: Well-established💉 Vaccination Considerations
💉 If You're Getting Vaccinated
No specific vaccine interactions are known. However, consult your doctor before receiving any live vaccines while on this medicine.
📦 Storage Guide
✅ DO
Store refrigerated at 2°C to 8°C
❌ DON'T
Do not freeze
✅ DO
Keep in original carton to protect from light
❌ DON'T
Do not expose to direct sunlight
✅ DO
Use immediately after opening
❌ DON'T
Do not store opened vial for later use
✈️ Traveling with This Medicine
Carry this medicine in its original packaging with a copy of your prescription. It must be stored refrigerated (2°C to 8°C); use a cool pack during travel. Inform security personnel if carrying needles. Plan injections around travel to avoid missed doses. Consult your doctor before traveling.
💰 Cost Analysis & Savings
👥 Real Patient Stories
Educational, anonymized scenarios. Individual results may vary.
💬 Questions Patients Often Ask
A: Visual improvement may be noticed within 1-2 weeks, but maximum effect may take several weeks to months with repeated injections.
A: The eye is numbed with anesthetic drops, so the injection is usually not painful. You may feel mild pressure or discomfort.
A: No, you should not drive until your vision clears, as it may be temporarily blurred.
🤔 Common Patient Concerns
🛑 Myths vs. Facts
- Myth: This injection can cure blindness permanently.
Fact: It can improve and preserve vision, but repeated injections are often needed to maintain effect. - Myth: It is a one-time treatment.
Fact: Treatment typically requires multiple injections over months or years. - Myth: It can be self-administered at home.
Fact: It must be given by a qualified ophthalmologist in a sterile setting.